Clinical Trials on Tobacco Cessation in Russian Federation

Total 14 results

McNeil AB

Completed

A Bioequivalence Study Between Two Nicotine Replacement Therapies in Adult Healthy Smokers Motivated to Quit.

Tobacco Dependence

Russian Federation
Valenta Pharm JSC

Completed

Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Sensor Technology for Deafblind
Central Clinical Hospital under President Affairs; Deaf-Blind Support Foundation... and other collaborators

Completed

Prospective Open Clinical and Genetic Study of Patients With Retinitis Pigmentosa (RU-RP)

Retinitis Pigmentosa | Usher Syndromes

Russian Federation
Sensor Technology for Deafblind
Deaf-Blind Support Foundation Con-nection; Federal State Budgetary Institution... and other collaborators

Completed

Clinical and Genetic Testing of Patients With Usher Syndrome

Retinitis Pigmentosa | Usher Syndrome | Congenital Deafness

Russian Federation
I.M. Sechenov First Moscow State Medical University

Recruiting

Metabolic Disorders and Vertigo

Vestibular Migraine | Meniere Disease | Vestibular Neuritis | Benign Paroxysmal Positional Vertigo (BPPV) | Central Positional Vertigo

Russian Federation
Valenta Pharm JSC

Recruiting

Efficacy and Safety of Vespireit, Sustained-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo

Vertigo | Autonomic Dysfunction

Russian Federation
Pfizer

Completed

Smoking Cessation Study In Healthy Adolescent Smokers

Smoking Cessation

United States, Korea, Republic of, Taiwan, Canada, Georgia, Russian Federation
Abbott

Completed

Effectiveness of Betaserc® (Betahistine Dihydrochloride) in Patients With Vestibular Vertigo in Routine Practice (VIRTUOSO)

Vertigo

Russian Federation, Ukraine
Pfizer

Completed

Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression

Depression | Smoking Cessation

Spain, United States, Hungary, Germany, Bosnia and Herzegovina, Croatia, Romania, Russian Federation
Pfizer

Completed

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders. (CATS)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
Pfizer
GlaxoSmithKline

Completed

Study Evaluating The Safety And Efficacy Of Varenicline and Bupropion For Smoking Cessation In Subjects With And Without A History Of Psychiatric Disorders (EAGLES)

Smoking Cessation

United States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia, Argentina
Novartis Pharmaceuticals

Completed

A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (KITE)

Diabetic Macular Edema

Czechia, India, Russian Federation, Taiwan, Turkey, Lebanon, Denmark, Estonia, France, Germany, Hungary, Korea, Republic of, Latvia, Lithuania, Bulgaria, Norway, Belgium, Malaysia, Sweden, Slovakia, Singapore, Poland, Switzerland
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion (RAPTOR)

Branch Retinal Vein Occlusion

China, Austria, Czechia, Russian Federation, Taiwan, United Kingdom, Canada, Japan, United States, France, Israel, Germany, Italy, Hong Kong, Spain, Denmark, Slovakia, Puerto Rico, Switzerland
Novartis Pharmaceuticals

Terminated

Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (RAVEN)

Central Retinal Vein Occlusion

China, Czechia, Germany, Russian Federation, Turkey, United States, Australia, Canada, Spain, United Kingdom, Thailand, Israel, Netherlands, Italy, Hungary, France, Greece, Puerto Rico, Malaysia, Japan

Clinical Trials on Tobacco Cessation in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Togo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations